polystyrene sulfonate

DRUG2 trials

Sponsors

Mario Negri Institute For Pharmacological Research IRCCS, National Center for Research Resources (NCRR)

Conditions

Hyyperkalemia in CKD stage IIIB to V patientsPseudohypoaldosteronism

Phase 2

Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I

CompletedNCT00004328

National Center for Research Resources (NCRR)Pseudohypoaldosteronism

Start: 1992-12-31Target: 1Updated: 2005-06-24

Phase 3

A Prospective, double-blind, randomized, single centre trial to evaluate the rate of RAAS inhibitor withdrawal or down-titration in non-dialysis patients with CKD stage IIIB to Vrandomized to Patiromer or placebo

CompletedCTIS2023-503984-41-00

Mario Negri Institute For Pharmacological Research IRCCSHyyperkalemia in CKD stage IIIB to V patients

Start: 2023-08-02End: 2024-10-16Target: 1Updated: 2023-10-17